Zydus Lifesciences Ltd
company logo

Zydus Lifesciences Ltd

Pharmaceuticals
Large Cap

-

- (0%)


Zydus Lifesciences Ltd Performance

-

-

-

-


-

-

-

-

-

Zydus Lifesciences Ltd Fundamentals

1,19,223.63Cr

30.89

6.01

0.05

38.36

0.25%

197.07

i buttonClick here to know more about Fundamentals

Zydus Lifesciences Ltd F&O

Zydus Lifesciences Ltd Option Chainright-arrow

Zydus Lifesciences Ltd Financials

Zydus Lifesciences Ltd Financialsright-arrow

Zydus Lifesciences Ltd Shareholding Pattern

Zydus Lifesciences Ltd Delivery and Volume

About Zydus Lifesciences Ltd

Zydus Lifesciences Ltd. (Formerly known as Cadila Healthcare Ltd.) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage hu

Pankaj R Patel

1995

ZYDUSLIFE

NameDesignation
Pankaj R PatelChairman (Non-Executive)
Sharvil P PatelManaging Director
Mukesh M PatelDirector
Nitin Raojibhai DesaiIndependent Director
H Dhanrajgir Director
Dharmishta N RawalIndependent Director
A S Diwanji Director
Apurva S DiwanjiIndependent Director
Upen H Shah Company Secretary
Ganesh N NayakExecutive Director
Bhadresh K ShahIndependent Director
Dhaval N SoniCompany Sec. & Compli. Officer
Akhil A. MonappaIndependent Director
Upasana Konidela.Independent Director
News and Events...

Similar Stocks

What's Trending

Zydus Lifesciences Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Zydus Lifesciences Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Zydus Lifesciences Ltd's share price is ₹1184.8 as of 2024-07-17.
Zydus Lifesciences Ltd's P/E ratio is 30.89 times as of 2024-07-17.
Zydus Lifesciences Ltd's most recent financial reports indicate a price-to-book ratio of 6.01, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Zydus Lifesciences Ltd's market capitalization is ₹119223.63 Cr as on 2024-07-17.
The current financial records of Zydus Lifesciences Ltd show a 23.45% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Zydus Lifesciences Ltd's most recent financial filings, the company has a total asset value of ₹8091.2, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Zydus Lifesciences Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Zydus Lifesciences Ltd's 52-week high and low as of 2024-07-17 are ₹1197.7 and ₹1177.6, respectively.